Levi & Korsinsky Notifies Shareholders of Regeneron Pharmaceuticals, Inc. (REGN) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...
Mumbai: Leading Pharma Firm Duped Of ₹22.31 Crore In Sophisticated Cyber Scam; Case Registered
Mumbai: A leading Indian pharmaceutical company has fallen victim to a sophisticated cyber fraud, losing ₹22.31 crore in an elaborate email scam. The fraud was uncovered when the company’s finance ...
JD Supra2d
Investigations Newsletter: Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million
Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Regeneron Pharmaceuticals, Inc.(REGN) Shareholders
NEW YORK, NY / ACCESS Newswire / February 2, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...
Trump sketches unprecedented plan for sweeping tariffs
President Trump Friday dramatically expanded his plans for a global trade war, confirming that he will impose tariffs on ...
Former pharmaceutical executive in Boston gets prison time for insider trading
A former executive of a global pharmaceutical company in Boston was sentenced Thursday for earning more than $250,000 through ...
Allergan Defeats Whistleblower's Bid to Revive Fraud Suit (1)
A whistleblower lost his bid to reinstate a False Claims Act suit alleging that Allergan Inc. and Adamas Pharmaceuticals Inc. fraudulently obtained patents on two drugs to combat Alzheimer’s disease.